Scott Robotham
About Scott Robotham
Scott Robotham is a Principal Scientist at Bristol Myers Squibb in Princeton, New Jersey, with extensive experience in analytical chemistry and mass spectrometry.
Title and Current Position
Scott Robotham holds the position of Principal Scientist at Bristol Myers Squibb in Princeton, New Jersey, United States. In this role, he is responsible for leading scientific research and contributing to the development of new pharmaceutical products.
Professional Experience at Bristol Myers Squibb
Scott Robotham has a substantial history at Bristol Myers Squibb, having served in various capacities. Prior to his current role, he was a Senior Scientist from 2018 to 2021 and a Research Investigator from 2015 to 2018. Throughout his tenure, he has significantly contributed to pharmaceutical research and development initiatives.
Academic and Research Roles at The University of Texas at Austin
Scott Robotham has an extensive academic background from The University of Texas at Austin. He served as a Research Scientist, Lecturer in Chemistry, Mass Spectrometry Facility Graduate Assistant, Graduate Teaching Assistant, and Graduate Research Assistant. These roles, held between 2009 and 2015, involve teaching, conducting research, and assisting in advanced mass spectrometry applications.
Educational Background
Scott Robotham earned his Doctor of Philosophy (Ph.D.) in Analytical Chemistry from The University of Texas at Austin, where he studied from 2009 to 2015. He also holds a Bachelor’s Degree in Chemistry from Nebraska Wesleyan University, obtained between 2004 and 2009. His academic credentials form a strong foundation for his career in scientific research.
Areas of Expertise
Scott Robotham has specialized expertise in mass spectrometry, particularly its applications in pharmaceutical research. He has authored several peer-reviewed publications in analytical chemistry and presented his research findings at national and international scientific conferences. His work includes developing new analytical methods for drug discovery and development.